Physician profile
Michelle M Meyer
NPI 1972850329
$1,657.59
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $575 · 2022: $499 · 2023: $459 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.16 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $270.39 | 2021-2022 | |
| Axsome Therapeutics, INC. | $187.52 | 2023 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $167.75 | 2021-2023 | Nuedexta, Rexulti, Abilify Maintena |
| Alkermes, INC. | $144.72 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.34 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $90.95 | 2022-2023 | Qelbree |
| Janssen Pharmaceuticals, INC | $82.99 | 2021-2023 | Invega Trinza, Invega Sustenna |
| Corium, LLC | $61.56 | 2022-2023 | Azstarys |
| Avanir Pharmaceuticals, INC. | $53.98 | 2022 | |
| Sunovion Pharmaceuticals INC. | $49.31 | 2021 | |
| Adlon Therapeutics L.P. | $34.47 | 2021 | |
| Neos Therapeutics, LP | $26.24 | 2022 | |
| Lundbeck LLC | $17.18 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.23 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $15.36 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.25 | 2021 | |
| Bausch Health US, LLC | $13.19 | 2023 | Aplenzin, Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.